IncFact
Company Profiles: Revenue, Growth, Competition

ADAPTIVE BIOTECHNOLOGIES Revenue, Growth & Competitor Profile

DBA ADAPTIVE
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Adaptive Biotechnologies

Access the complete profile.

Adaptive Biotechnologies Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees500 - 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes541711 Research & Development in Biotechnology
541714
Address1551 Eastlake Ave E
Suite 200
Seattle, WA 98102

adaptivebiotech.com
Note: Revenues for privately held companies are statistical evaluations.


Adaptive Biotechnologies's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. It is classified as operating in the Scientific Research & Development Services industry.


Adaptive Biotechnologies's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Adaptive Biotechnologies Annual Revenue and Growth Rate

Adaptive Biotechnologies Revenue Est.
($ Million)
Growth Rate (%)# Employees
2021 Details in Premium Report
2020
2019
2018
2017


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Adaptive Biotechnologies's revenues are gauged from an analysis of company filings.



Investor Activity

Adaptive Biotechnologies has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
May 11, 2015 16 100%$195 MM
Complete list of funding rounds and total amounts in the Company Report




Adaptive Biotechnologies's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Adaptive Biotechnologies Revenue (Sales) Adaptive Biotechnologies Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Adaptive Biotechnologies is developing and marketing. Adaptive Biotechnologies's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
T-DETECT
Pharmaceutical, medial and veterinary preparations; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
06/03/2022
T T-DETECT
Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
01/22/2021
T
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
01/22/2021

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Adaptive Biotechnologies grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Adaptive Biotechnologies is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Adaptive Biotechnologies's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adaptive Biotechnologies, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSFairmont, WV100 
OMNICAREAnnapolis Junction, MD92 
NETCRAKER TECHNOLOGYWaltham, MA85 
INC RESEARCHRaleigh, NC58 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM53 
FORCE ENGINEERINGChandler, AZ45 
CEPHALONFrazer, PA41 
LABCORP DRUG DEVELOPMENTBurlington, NC40 
PRA INTERNATIONAL OPERATIONSRaleigh, NC33 




Nearby Competitors

These companies are similar in business line and location to Adaptive Biotechnologies. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
FRED HUTCHINSON CANCER RESEARCH CENTERSeattle, WA100 
ADAPTIVE BIOTECHNOLOGIESSeattle, WA18 
ALLEN INSTITUTESeattle, WA10 
BARDY DIAGNOSTICSSeattle, WA8 
SANA BIOTECHNOLOGYSeattle, WA7 
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASONSeattle, WA5 




Future Competition: Adaptive Biotechnologies's Fastest Growing Competitors

These companies are in the same general field as Adaptive Biotechnologies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Adaptive Biotechnologies Competitors